top of page

Intranasal Ketamine for Suicidal Ideation in Veterans

About the study

NCT Trial Number

NCT03788694

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Bronx Veterans Medical Research Foundation, Inc|Icahn School of Medicine at Mount Sinai

noun_date_3237048.png

Trial Start Date

Jan-20

noun_capsule_138144.png

About the participants

Age seeking

21 Years to 70 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Suicidal Ideation

noun_square_138133.png

Accepts healthy volunteers?

No

This study will investigate the safety, efficacy, and feasibility of multiple doses of intranasal (IN) ketamine for suicidal ideation Veterans.

Eyes Graffiti

Locations

United States, New York
James J. Peters VA Medical Center
Bronx, New York, United States, 10468

Contact: Rachel Harris, MA
718-584-9000 ext 3718
Rachel.Harris6@va.gov

Contact: Rene Kahn, MD
718-584-9000 ext 5225
rene.kahn@mssm.edu

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page